Viewing StudyNCT02450903

Bugs

eRecord

Ignite Creation Date: 2024-05-06 @ 4:05 AM

Last Modification Date: 2024-10-26 @ 11:43 AM

Study NCT ID: NCT02450903

Status: COMPLETED

Last Update Posted: 2021-03-30

First Post: 2015-05-08

Brief Title: LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib

Sponsor: Novartis Pharmaceuticals

Organization: Novartis

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Name

Non-Small-Cell Lung Cancer

Keywords:

Name	View

NSCLC	View
Non-Small-Cell Lung Cancer	View
ALK	View
LDK378	View
alectinib	View
Non-small cell lung carcinoma NSCLC	View
lung cancer	View
lung adenocarcinoma	View
Non small cell lung carcinoma	View
Non small cell lung cancer	View
Non-small cell lung cancer	View